Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
FactSet Research Systems Inc is a financial data & stock exchanges business based in the US. FactSet Research Systems shares (FDS) are listed on the NASDAQ and all prices are listed in US Dollars. FactSet Research Systems employs 10,622 staff and has a trailing 12-month revenue of around USD$1.5 billion.
|52-week range||USD$193.3363 - USD$361.0558|
|50-day moving average||USD$314.5371|
|200-day moving average||USD$329.2921|
|Wall St. target price||USD$307.92|
|Dividend yield||USD$3.03 (0.97%)|
|Earnings per share (TTM)||USD$9.84|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing FactSet Research Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of FactSet Research Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
FactSet Research Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 31x. In other words, FactSet Research Systems shares trade at around 31x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
FactSet Research Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.5057. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into FactSet Research Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
FactSet Research Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$506 million.
The EBITDA is a measure of a FactSet Research Systems's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.5 billion|
|Operating margin TTM||29.53%|
|Gross profit TTM||USD$798.7 million|
|Return on assets TTM||14.49%|
|Return on equity TTM||46.24%|
|Market capitalisation||USD$11.7 billion|
TTM: trailing 12 months
There are currently 1.0 million FactSet Research Systems shares held short by investors – that's known as FactSet Research Systems's "short interest". This figure is 39% up from 738,478 last month.
There are a few different ways that this level of interest in shorting FactSet Research Systems shares can be evaluated.
FactSet Research Systems's "short interest ratio" (SIR) is the quantity of FactSet Research Systems shares currently shorted divided by the average quantity of FactSet Research Systems shares traded daily (recently around 214734.51882845). FactSet Research Systems's SIR currently stands at 4.78. In other words for every 100,000 FactSet Research Systems shares traded daily on the market, roughly 4780 shares are currently held short.
However FactSet Research Systems's short interest can also be evaluated against the total number of FactSet Research Systems shares, or, against the total number of tradable FactSet Research Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case FactSet Research Systems's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 FactSet Research Systems shares in existence, roughly 30 shares are currently held short) or 0.0347% of the tradable shares (for every 100,000 tradable FactSet Research Systems shares, roughly 35 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against FactSet Research Systems.
Find out more about how you can short FactSet Research Systems stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like FactSet Research Systems.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 21.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and FactSet Research Systems's overall score of 21.8 (as at 01/01/2019) is pretty good – landing it in it in the 25th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like FactSet Research Systems is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 3.72/100
FactSet Research Systems's environmental score of 3.72 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that FactSet Research Systems is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 9.76/100
FactSet Research Systems's social score of 9.76 puts it squarely in the 2nd percentile of companies rated in the same sector. This could suggest that FactSet Research Systems is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 8.82/100
FactSet Research Systems's governance score puts it squarely in the 2nd percentile of companies rated in the same sector. That could suggest that FactSet Research Systems is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
|Total ESG score||21.8|
|Total ESG percentile||25.26|
|Environmental score percentile||2|
|Social score percentile||2|
|Governance score percentile||2|
Dividend payout ratio: 27.57% of net profits
Recently FactSet Research Systems has paid out, on average, around 27.57% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.99% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), FactSet Research Systems shareholders could enjoy a 0.99% return on their shares, in the form of dividend payments. In FactSet Research Systems's case, that would currently equate to about $3.03 per share.
While FactSet Research Systems's payout ratio might seem fairly standard, it's worth remembering that FactSet Research Systems may be investing much of the rest of its net profits in future growth.
FactSet Research Systems's most recent dividend payout was on 18 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 February 2021 (the "ex-dividend date").
FactSet Research Systems's shares were split on a 3:2 basis on 7 February 2005. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your FactSet Research Systems shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for FactSet Research Systems shares which in turn could have impacted FactSet Research Systems's share price.
Over the last 12 months, FactSet Research Systems's shares have ranged in value from as little as $193.3363 up to $361.0558. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while FactSet Research Systems's is 0.7567. This would suggest that FactSet Research Systems's shares are less volatile than average (for this exchange).
FactSet Research Systems Inc. provides integrated financial information and analytical applications to the investment and corporate communities in the Americas, EMEA, and the Asia Pacific. The company delivers insight and information through the workflow solutions of research, analytics and trading, content and technology solutions, and wealth. It serves a range of financial professionals, which include portfolio managers, investment research professionals, investment bankers, risk and performance analysts, wealth advisors, and corporate clients. FactSet Research Systems Inc. was founded in 1978 and is headquartered in Norwalk, Connecticut.
Everything we know about the Reddit IPO, plus information on how to buy in.
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
Everything we know about the Procore IPO, plus information on how to buy in.
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Bukalapak IPO, plus information on how to buy in.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.